Facebook Instagram Linkedin Twitter Youtube
  • News
  • Client
    • Asset Managers
    • Investment Banks
    • Private Companies
    • Public Companies
  • Services
  • Opportunities
    • Internship
    • Career
  • About
    • About Us
    • Engagement Model
    • Team
  • Contact
  • Coverage
Search
17.9 C
New York
Tuesday, July 22, 2025
Facebook Instagram Linkedin Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
  • Home
  • Services
  • Blog
  • About
  • Contact
  • FacebookInstagram

Avise Analytics

  • News
  • Client
    • AllAsset ManagersInvestment BanksPrivate CompaniesPublic Companies
      Menu Client

      Asset Managers

      Menu Client

      Investment Banks

      Menu Client

      Private Companies

      Menu Client

      Public Companies

  • Services
    • Menu Services

      Equity Research

      Menu Services

      Valuation Modeling

      Menu Services

      Corporate Presentations

      Menu Services

      Business Plans

      Menu Services

      Blog Writing

  • Opportunities
    • Internship
    • Career
  • About
    • About Us
    • Engagement Model
    • Team
  • Contact
  • Coverage
Biotechnology

Gene Therapy and Exon Skipping offer hope for patients with Duchenne...

Avise Analytics - April 18, 2019 0
Biotechnology

Is Autologous Stem Cell Therapy the next frontier of medicine?

Avise Analytics - April 11, 2019 0
Biotechnology

Fighting Parkinson’s: Novel Therapeutics could prove to be game-changers

Avise Analytics - April 11, 2019 0
Biotechnology

New Therapeutics rise to the occasion for the treatment of Erectile Dysfunction

Avise Analytics - April 9, 2019 0
Disruptive

Will Apple’s revolutionary approach herald a new era for the Credit...

Avise Analytics - April 4, 2019 0
Biotechnology

Experimental Drugs offer hope for Breast Cancer Patients

Avise Analytics - April 2, 2019 0
Biotechnology

Emerging Gene Therapy comes to the aid of hearing loss patients

Avise Analytics - April 2, 2019 0
Biotechnology

Scientific Breakthrough seeks to end the suffering of people with Vitiligo

Avise Analytics - March 29, 2019 0
Biotechnology

Is a cure for Alopecia Areata on the horizon? New research...

Avise Analytics - March 22, 2019 1
Biotechnology

Robotic Exoskeletons and Stem Cells offer hope to Paraplegics

Avise Analytics - March 22, 2019 0
1...456...8Page 5 of 8

Recent Comments

  • Marina Torres on 5 Promising Stocks In The Stroke Management Industry
  • Finlay Cedar on New Age Therapeutics Offer Hope to Patients of Multiple Sclerosis
  • Tshepo Prence on New therapeutics promise respite to patients suffering from COPD
  • Finlay Cedar on Is a cure for Alopecia Areata on the horizon? New research shows promise
  • Anton on THE FUTURE OF HEPATITIS-B TREATMENT [ MUST WATCH ]

EDITOR PICKS

Parcel Pal Technologies – On the Quick Road to Success

June 26, 2019

Gene Therapy offers Cure for Bubble Boy Syndrome

June 20, 2019

Curaleaf Holding: Forging the largest acquisition in U.S cannabis landscape

May 6, 2019

POPULAR POSTS

New therapeutics promise respite to patients suffering from COPD

February 27, 2019

New Age Therapeutics Offer Hope to Patients of Multiple Sclerosis

February 13, 2019

5 Promising Stocks In The Stroke Management Industry

January 17, 2019

POPULAR CATEGORY

  • Biotechnology61
  • Clinical Trials59
  • FDA58
  • Trending57
  • IND52
  • Results48
  • Industry44
  • NDA37
  • Menu Client20
ABOUT US
Founded in 2012, Avise Analytics is the fastest growing equity research firm that authors institutional quality equity research reports, with special focus on Nano-Cap and Micro-Cap companies that are undervalued and lack adequate coverage. Avise is an approved research contributor on premier investor platforms such as Thomson Reuters, Factset and CaptialIQ.
Contact us: info@aviseanalytics.com
FOLLOW US
Facebook Instagram Linkedin Twitter Youtube
  • Disclaimer
  • Privacy
  • Contact Us
© Copyright 2019 aviseanalytics.com | All Rights Reserved.

REQUEST FREE COVERAGE

We also publish independent equity research reports, articles and interview videos on micro cap and small cap companies based on our initial research and investors interest.

We encourage OTC or NASDAQ based PUBCOS to reach out for a free coverage report.

EMAIL US

GET ON THE LIST

Join our mailing list for latest coverage reports and articles, and our special coverage videos of daily market analysis on small cap companies - "Lastday Movers"

    WORK WITH US

    We are looking for talented interns to learn and help investors find valuable companies.

    APPLY